CTOs on the Move

Venclose

www.venclose.com

 
We are a medical technology company developing next-generation solutions for the treatment of chronic venous insufficiency, a progressive medical condition affecting an estimated 10% of adults.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Venclose raised $27M on 12/04/2019

Similar Companies

Young Dental

Young Dental is a Earth City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Juvent Medical Inc

Juvent Medical Inc is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

INNOVATIVE BIOCERAMIX

INNOVATIVE BIOCERAMIX INC. is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pelstar LLC

Pelstar LLC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

MY01

MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.